Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

RS 49014

Known as: RS-49014 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
Single oral doses (5, 10 and 15 mg) of the new H1-receptor antagonist 3,7-dihydro-7-[2-hydroxy-3-[4-[3-phenylthio) propyl]-1… Expand
1986
1986
3,7-Dihydro-7-[2-hydroxy-3-[4-[3-(phenylthio) propyl]-1-piperazinyl]propyl]-1,3-dimethyl-1H-purine-2,6-dione dihydrochloride… Expand
1985
1985
A series of 3,4-dihydro-1,3-dimethyl-7-[3-(4-substituted-piperazin-1-yl)- substituted-alkyl]-1H-purine-2,6-diones and 3,7-dihydro… Expand